Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  Astellas Pharma Inc    4503   JP3942400007

ASTELLAS PHARMA INC (4503)

10
SummaryChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Astellas Pharma : Transfer of Distribution Rights for Targocid® and Maalox®

09/08/2011 | 10:10pm US/Eastern

Astellas Pharma Inc. (“Astellas Pharma”; Headquarters: Chuo-ku, Tokyo; President and CEO: Yoshihiko Hatanaka) and sanofi-aventis K.K. (“sanofi-aventis”; Headquarters: Shinjuku-ku, Tokyo; Representative Director and President: Jez Moulding) announced that Astellas Pharma will transfer the rights to distribute the injectable antibiotics Targocid® (generic name: teicoplanin) and the treatment for peptic ulcer and gastritis Maalox® (generic name: dried aluminum hydroxide gel and magnesium hydroxide) to sanofi-aventis effective on January 1, 2012. This transfer of distribution rights is taking place based on the expiration of the contract.

<Products for which distribution rights will be transferred>

React to this article
Latest news on ASTELLAS PHARMA INC
04:46a ASTELLAS PHARMA : Study Data from Astellas Pharma, Inc. Update Knowledge of Proi..
01:41a MEDIVATION : and Astellas Pharma Reports Results from Phase 2 Terrain Trial
01/28 ASTELLAS PHARMA : New Chemometrics Findings from Astellas Pharma, Inc. Described..
01/28 MEDIVATION : and Astellas Pharma Releases Results from Phase 2 Terrain Trial
01/23 MEDIVATION : Astellas -enzalutamide phase 2 terrain trial demonstrated statistic..
01/22 ASTELLAS PHARMA : Announces FDA Anti-Infective Drugs Advisory Committee Recommen..
01/14 ASTELLAS PHARMA : Partners With Society of Cardiovascular Patient Care To "Bring..
01/14 ASTELLAS PHARMA : Reports from Astellas Pharma, Inc. Describe Recent Advances in..
01/08 ASTELLAS PHARMA : Reports from Astellas Pharma, Inc. Highlight Recent Findings i..
01/01 ASTELLAS PHARMA : New Findings from Astellas Pharma, Inc. in the Area of Clinica..
Advertisement
Chart
Duration : Period :
Astellas Pharma Inc Technical Analysis Chart | 4503 | JP3942400007 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF